Biotech

All Articles

2 cancer biotechs merge, creating international footprint

.OncoC4 is actually taking AcroImmune-- and its internal scientific production abilities-- under its...

Amgen files very first period 3 win for $400M eczema medication

.Amgen has shared (PDF) the first period 3 information on its $400 million chronic eczema medicine, ...

Biogen, UCB document phase 3 lupus gain after stopping working earlier test

.Biogen and also UCB's bet one's bottom dollar improving into stage 3 astride a broken research seek...

Aptadir hopes brand-new RNA inhibitors can reverse complicated cancers cells

.Italian biotech Aptadir Therapeutics has actually launched along with the pledge that its own pipe ...

Wave surfs DMD results to regulatory authorities' doors, delivering stock up

.Wave Life Sciences has actually fulfilled its own goal in a Duchenne muscular dystrophy (DMD) resea...

Sanofi picks brand new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is returning to the pharma layer, using u...

Achilles drops tissue treatment plan, supports for discharges after missing out on 'office practicality' objectives

.Achilles Therapeutics has actually destroyed its technique. The British biotech is quiting working ...

Aligos heralds period 2 MASH succeed, reducing liver excess fat around 46%

.Aligos Therapies is actually heralding a midstage win in metabolic-dysfunction linked steatohepatit...

Basilea credit ratings $268M BARDA backing for antifungals, antibiotics

.Basilea Pharmaceutica's job creating brand new antifungals has obtained a substantial improvement f...

Capricor offers Europe liberties to late-stage DMD treatment for $35M

.Possessing currently gathered up the united state rights to Capricor Rehabs' late-stage Duchenne mu...